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The adjusted incidence of cervical carcinoma among Israeli Jewish women is B5 out of 100000. This retrospective study sought to
determine the clinical implications of finding atypical glandular cells of undetermined significance (AGUS) in cervical cytologic
specimens in this population. Cervical cytologic examinations during January 2001–June 2003 diagnosed as AGUS were identified by
a computerised database. Medical records were reviewed to determine the presence or absence of associated significant pathologic
conditions of the cervix and identified 45 out of 11800 patients (0.38%) with AGUS. AGUS was the only cytologic diagnosis in 14
patients, while 31 patients had both AGUS and an additional atypical squamous cell of undetermined significance (ASCUS). All
subjects underwent colposcopy, endocervical curettage, and cervical biopsy. A clinically significant diagnosis (cervical intraepithelial
neoplasia (CIN) II, CIN III, or carcinoma) was made in 24 patients (53.3%), including cancer in three (6.7%): one had microinvasive
adenocarcinoma and two had microinvasive squamous cell carcinoma. Squamous carcinoma coexisting with a clinically significant
lesion carried a risk of 61.3%, compared with a risk of 35.7% for AGUS alone (P¼0.20). Detection of AGUS during cervical cytologic
screening, especially with a coexisting ASCUS, indicates the existence of serious pathologic processes; management by cervical
colposcopy, endocervical curettage, and cervical biopsy is recommended.
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Israeli Jewish women are at low risk for cancer of the uterine cervix
(Sadan et al, 2003). Cervical carcinoma ranks 20th among all their
cancers, with the adjusted incidence rate being B5 out of 100000,
a figure among the lowest worldwide. The data recently published
by Sadan et al (2003) now indicate similar incidence rates for
premalignant lesions in Jewish Israeli women as observed in
Western countries. The current study was undertaken to evaluate
the efficacy of follow-up methods and the nature of the results of
atypical glandular cells of undetermined significance (AGUS)
detected on cervical Pap smears in this unique population.
The Bethesda System for cytologic reporting of Papanicolaou
(Pap) smears was originally developed in 1988 (revised in 1991) in
order to provide a standardised method of reporting cytologic
findings for facilitating peer review and quality assurance. The
2001 version of the Bethesda System reflects the most current
knowledge about the biology of Pap test abnormalities (Solomon
et al, 2002).
In the current paper, we used the term ‘atypical cell’ to describe
those cellular changes that are neither characterised by infection
nor any preneoplastic, neoplastic, or reparative processes, and not
to denote inflammatory or reactive cellular changes. The term
AGUS was reserved for atypical cells in which a glandular origin
was suspected, and the term ‘atypical squamous cells of
undetermined significance’ (ASCUS) was reserved for atypical
cells in which a squamous origin was suspected.
In contrast to both preinvasive and neoplastic squamous lesions
of the cervix, where the evaluation and treatment are usually
straightforward, glandular lesions of the cervix are diagnostically
and therapeutically more challenging to the cytopathologist and
clinician because of their relative rarity, the relative absence of
colposcopic findings, irregular shedding, small size, endocervical
location (making lesions less amenable to cytologic sampling), and
broader differential diagnosis (Goff et al, 1992). Moreover, benign
conditions such as cervical endometriosis, tubal metaplasia, a
history of cone biopsy, Gartner’s ducts, microglandular hyperpla-
sia, deciduosis, and even endometrial glands in the upper cervical
canal can make the differential diagnosis a difficult task (Pacey
et al, 1988; Novotny et al, 1992; Lee, 1993).
The classification of glandular abnormalities was significantly
revised in the 2001 Bethesda System, reflecting a reappraisal of the
strengths and weaknesses of cytology in assessing these findings.
According to that system, glandular cell abnormalities are
classified as ‘atypical endocervical, endometrial, or glandular
cells.’ In most cases, the morphological features of the condition
enable differentiating between atypical endometrial and endocer-
vical cells (Wilbur, 1997). The management of patients with
glandular abnormalities may vary significantly, depending upon
cell type, thus justifying making this distinction when possible.
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This study was conducted over a period of 2 years and 6 months
(from January 2001 to June 2003). During this period, 11800
patients were examined by the Colposcopic Unit of the Balfour-
Maccabi Women’s Healthcare Center (Tel-Aviv, Israel). This unit
is a public facility and is subsidised by the national governmental
health insurance scheme. Two senior gynecologists who are
specialists in cervical medicine performed the colposcopies (RB
and ES).
Of these 11800 samples, 45 (0.38%) Pap smears showed AGUS
and comprised our study data. These 45 women were examined by
colposcopic examination, colposcopic-directed biopsy, cone
biopsy, and/or endocervical curettage.
The medical records of all AGUS patients were reviewed and the
retrieved data consisted of the woman’s age, gravidity, parity,
menopausal status, as well as any history of abnormal bleeding,
smoking, use of oral contraceptives, intrauterine devices, replace-
ment of hormones, prior abnormal Pap smear, or previous cancer.
In addition, the results of the clinical evaluation of their AGUS
smear were collected, including the findings of the physical
examination, colposcopy, cytology, and biopsy results. Cervical
biopsies were classified according to the modified Richart
classification system for cervical intraepithelial neoplasia (CIN),
where lesions consistent with flat condyloma and CIN I are
referred to as ‘low-grade CIN’ and lesions consistent with CIN II or
CIN III are grouped together as ‘high-grade CIN’ (Richart, 1990).
The AGUS pap smears in this study were reviewed by a single
cytopathologist. For the purposes of this study, a ‘clinically
significant lesion’ was defined as CIN II, CIN III, or carcinoma.
CIN I was not considered a clinically significant lesion and was
therefore classified as benign.
RESULTS
There were 45 patients (mean age 41.3 years) in the study cohort.
The smears of 14 of them (31%) were reported as due to AGUS
alone and 31 (69%) smears had coexistent squamous pathology.
Seven (16%) patients had a recent history of abnormal vaginal or
postcoital bleeding. Four patients had a history of nongynecologic
cancer: three had breast cancer and one had carcinoma of the
rectum. One of the patients was pregnant at the time of her AGUS
cytology finding.
All 45 patients were colposcoped and biopsied shortly after
AGUS was confirmed: 16 women (36%) underwent colposcopy
with cervical biopsies, 29 (64%) underwent colposcopy with
cervical biopsies and endocervical curettage, and 25 (55%) of the
women who underwent cervical biopsies required diagnostic
conisation during their workup. Since our protocol dictates that
women with AGUS and without clear external lesions undergo
endocervical curettage, the 16 women who had clear external
lesions did not undergo this procedure.
Table 1 shows the pathology identified in the smears of the study
group. Table 2 compares the pathology found in women with
AGUS with and without concomitant squamous abnormalities. A
patient diagnosed with coexistent ASCUS carried a risk factor of
61.3% for the existence of a clinically significant lesion, compared
with a risk of 35.7% for AGUS alone. When Fischer’s exact test was
used to compare these groups, however, the women with
coexistent squamous abnormalities detected by a Pap smear were
not found to have significantly more cervical lesions than women
with AGUS alone (P40.05). Only one of the 45 patients with AGUS
was found to have adenocarcinoma of the cervix.
In total, 14 (31%) of the study patients were postmenopausal,
and our results indicated that both premenopausal and post-
menopausal patients were at risk for clinically significant lesions.
Moreover, there was no difference between pre- and postmeno-
pausal women in terms of pathology. Even so, endometrial biopsy
is recommended in postmenopausal women with Pap-diagnosed
AGUS who do not have an external lesion on cervical or
endocervical biopsy. All of our postmenopausal study women
had significant cervical lesions and did not require endometrial
biopsy.
DISCUSSION
Glezerman et al (1989) noted a remarkable, although not
statistically significant, increase in the number of Israeli Jewish
women patients with cervical cancer. Sadan et al (2003) retro-
spectively analysed the results of 297849 Pap smears during 9
years (1991–1999), and their data indicated similar incidence rates
for premalignant lesions in Jewish Israeli women as observed in
Western countries. Bar-Am et al (1995) found that the prevalence
of abnormal cytology among the Israeli women was almost the
same as that of a non-Jewish group (24 out of 1000 and 26 out of
1000, respectively), and that the distribution of the known risk
factors among the study group (number of sexual partners, age at
first intercourse, and age at first pregnancy) was practically the
same as those in the non-Jewish population. The authors
documented an increase of 29.2% (from 17 out of 1000 to 24 out
of 1000) in the prevalence of cervical premalignant lesions among
the Israeli women in their study group and noted that they were
younger when they became sexually active, had a larger number of
sexual partners, and fewer of them were married. In addition,
fewer of them were observant of Jewish ritual practices, one of
which is abstinence from intercourse during menstruation and for
1 week afterwards. We designed the current study to document
whether this growing similarity between Jewish Israeli and other
groups of women was also reflected by the pattern of AGUS in their
Pap smears and our findings showed that here, too, this population
no longer enjoys a comparatively lower risk.
The optimal clinical evaluation of the diagnosis of AGUS by the
Pap test has yet to be determined. Therefore, the clinician is faced
with uncertainty as to the aggressiveness of the abnormal cells and
the proper sequence of clinical evaluation. Some physicians choose
a conservative approach to AGUS and treat it much like ASCUS,
with repeated cytologic examination alone, whereas others take a
Table 1 Histopathology in the study women with AGUS smears
(n¼45)
Diagnosis n (%)
Normal 10 (22)
Cervicitis 4 (9)
CIN I 7 (15)
CIN II–III 21 (47)
Carcinoma 3 (7)
CIN¼cervical intraepithelial neoplasia; AGUS¼atypical glandular cells of uncertain
significance.
Table 2 Histopathology in women with AGUS smears with and without
coexistent squamous abnormalities
a
Diagnosis AGUS alone (n¼14) AGUS+ASCUS (n¼31)
Normal 4 6
Cervicitis 2 2
CIN I 3 4
CIN II–III 4 17
Carcinoma 1 2
aP¼NS between the two groups. ASCUS¼atypical squamous cell of undetermined
significance; CIN¼cervical intraepithelial neoplasia; AGUS¼atypical glandular cells of
uncertain significance.
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of the endocervix.
The diagnosis of AGUS is made in routine clinical practice in
0.13–2.5% of the smears; most rates quoted in the literature are
less than 1% (Goff et al, 1992; Nasu et al, 1993; Lee et al, 1995;
Ferris et al, 1996; Kennedy et al, 1996; Raab et al, 1997; Zweizig
et al, 1997). Thus, our diagnostic rate of 0.38% in this study is in
agreement with the current literature.
The present study reviewed a series of 45 patients with AGUS as
diagnosed by a cytologic screening exam. In previous studies, as
well as this one, AGUS has been associated with significant
histologic abnormalities in 53.3% of all cases, including cancer in
6.7% (Richart, 1990; Goff et al, 1992; Eddy et al, 1997; Zweizig et al,
1997; Veljovich et al, 1998). With one exception, all of these
abnormalities were confirmed by cytologic evaluation as being due
to AGUS and squamous in nature. In our study, the prevalence of
significant cervical disease was equally distributed between
premenopausal and postmenopausal cases.
The number of clinically significant lesions in the group we
studied is sufficiently high to suggest that a complete evaluation
(colposcopy with cervical biopsies, endocervical curettage, and
diagnostic conisation when needed) of all women with an AGUS
smear is warranted. An endometrial biopsy is warranted in the
absence of persistent AGUS in the cervical findings from the
biopsy (Zweizig et al, 1997).
We found significant squamous lesions in 51% of the AGUS
smears and only 2.2% glandular lesions. The possible explanation
for the relative absence of glandular pathology is the fact that the
cells were so badly deformed that they appeared to be glandular to
the cytopathologist but were actually squamous in origin.
Finally, the results of this study strongly support that the
presence of AGUS cells upon a routine cytologic specimen
examination indicates the existence of a pathologic condition that
mandates appropriate management.
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